Vaginal Sling Global Market Report 2024

The global vaginal sling market has grown strongly in recent years. It will grow from $1.40 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. During the historical period, growth can be attributed to several factors, including the increasing prevalence of stress urinary incontinence, advancements in surgical techniques related to its treatment, the growth of the aging population, obtaining regulatory approvals for related procedures or devices, and the ongoing development of healthcare infrastructure.

The global vaginal sling market is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. Anticipated growth in the forecast period is expected to result from various factors, including the rising demand for minimally invasive procedures, the continual increase in healthcare spending, the expansion of the geriatric population, a preference among patients for outpatient procedures, and the heightened awareness generated through marketing initiatives. Several major trends expected in this period encompass technological advancements, ongoing product innovations, the continued growth of minimally invasive procedures, a focus on global expansion and market penetration strategies, as well as the adoption of patient-centric approaches within the healthcare industry.

The increasing demographic of elderly women is anticipated to drive the expansion of the vaginal sling market in the future. This demographic, comprising individuals aged 65 and above, faces issues such as stress urinary incontinence (SUI) and other forms of urinary incontinence. These conditions are effectively treated with vaginal slings. As of January 2023, Statistics Netherlands reports a total female population of 2,172 residents in the Netherlands, with 95,090 women aged 90 and above. The rising number of elderly women is a significant factor contributing to the growth of the vaginal sling market.

The continual rise in healthcare sector expenditure is expected to fuel the growth of the vaginal sling market. Healthcare expenditure, expressed as a percentage of GDP, encompasses the total cost of healthcare, combining public and private spending. Increased healthcare spending not only fosters innovation and accessibility but also enhances education and the quality of care for those seeking treatment for stress urinary incontinence. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, the projected annual growth in national health spending between 2021 and 2030 is 5.1%, reaching nearly $6.8 trillion. The anticipated growth rates for Medicare and Medicaid spending further underline the driving force of healthcare sector expenditure on the vaginal sling market.

Prominent players in the vaginal sling market are adopting a strategic partnership approach to focus on urogynecology and female urology. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits. In September 2021, UroCure, a US-based healthcare company, entered into a partnership with LiNA Medical USA, a US-based medical device company. This collaboration, involving distribution and product development, capitalizes on UroCure's ArcTV sling and growing women's health portfolio, along with LiNA's specialized device solutions and dedicated US national sales force in urogynecology and female urology. The collaboration aims to create a comprehensive range of surgical solutions for female stress incontinence, with the inaugural product being UroCure's ArcTV sling - a medical device designed to alleviate the impact of stress urinary incontinence in women.

Leading companies in the vaginal slings market are actively innovating by introducing new products, particularly for the treatment of stress urinary incontinence (SUI). This strategic focus aims to capture larger customer bases, drive increased sales, and ultimately boost revenue. The treatment for SUI involves diverse approaches targeted at addressing the root causes and managing symptoms related to involuntary urine leakage during activities like coughing, sneezing, laughing, or physical exertion. In November 2021, Caldera Medical, a US-based medical device company, unveiled Desara TVez, a product uniquely designed to ensure the safe and effective surgical treatment of stress urinary incontinence. Beyond patient treatment, Desara TVez equips physicians with enhanced tools and implants, optimizing control and streamlining the procedural aspects.

In February 2022, Evoco, a US-based biotechnology company, completed the acquisition of Agency for Medical Innovation (AMI) for an undisclosed sum. Through this acquisition, Evoco aims to unlock the potential for value creation, strategically planning for elevated growth and collaborating closely with the existing management team. Agency for Medical Innovation, based in Austria, specializes in the manufacturing of vaginal slings.

Major companies operating in the vaginal sling market report are Betatech Medical Inc., Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, B. Braun Melsungen AG, Promedon GmbH, ABISS Pty Ltd., Lotus Surgicals Pvt. Ltd., American Medical Systems Holdings Inc., UroCure LLC, Neomedic International Ltd., Ethicon Inc., C. R. Bard Inc., Medtronic PLC, Agency for Medical Innovation, Abiss Analytic Biosurgical Solutions, Cook Group Incorporated, Sofradim Production SAS, Medesign Pharmaceuticals Private Limited, MedGyn Products Inc., Medica Europe BV, Medline Industries Inc., Organogenesis Holdings Inc., Prosurg Inc., Degania Medical Devices Pvt. Ltd., Regeneration Technologies Inc., SRS Medical Systems, Teleflex Inc., Uroplasty Inc., Urotech Co. Ltd., Urovision Diagnostics & Research Centre Private Limited, W.L. Gore & Associates Inc., Zimmer Biomet Holdings Inc., Johnson & Johnson Services Inc., CooperSurgical Inc., Endo International plc

North America was the largest region in the Vaginal Slings market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaginal sling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaginal sling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Different types of vaginal slings are available, including transobturator slings, tension-free vaginal tape slings, and others. Transobturator slings are a surgical approach used to treat stress urinary incontinence, employing a thin strip of permanent mesh. These slings utilize various materials such as tissue slings and synthetic slings, catering to different types of urinary incontinence like stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence. Various end-users, including hospitals, clinics, and other medical facilities, utilize these products in their practice.

This report provides vaginal sling market statistics, including the vaginal sling industry’s global market size, regional shares, competitors with a vaginal sling market share, detailed vaginal sling market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal sling industry. This vaginal sling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vaginal sling market consists of sales of allograft slings, mid-urethral retropubic slings, single-incision slings, and mini slings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.